The CLI Continuum of Care Model : A Multidisciplinary Approach to Improve Outcomes
暂无分享,去创建一个
Prakash | Renu | M. Joner | A. Schmidt | T. Zeller | Larry J Diaz-Sandoval | J. Mustapha | J. Wiley | T. Koppara | B. Purushottam | F. Saab | Krishnan | Brent Vantil | Virmani
[1] F. Vermassen,et al. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial. , 2014, Journal of the American College of Cardiology.
[2] C. St. Hilaire,et al. Medial vascular calcification revisited: review and perspectives. , 2014, European heart journal.
[3] D. Scheinert,et al. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. , 2014, JACC. Cardiovascular interventions.
[4] R. Engelberger,et al. Clinically-Driven Need for Secondary Interventions After Endovascular Revascularization of Tibial Arteries in Patients With Critical Limb Ischemia , 2013, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.
[5] I. Porto,et al. Drug-Eluting Balloon in Peripheral Intervention for Below the Knee Angioplasty Evaluation (DEBATE-BTK): A Randomized Trial in Diabetic Patients With Critical Limb Ischemia , 2013, Circulation.
[6] M. Dake,et al. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies. , 2013, Journal of the American College of Cardiology.
[7] M. Makaroun,et al. Predictors and outcomes of restenosis following tibial artery endovascular interventions for critical limb ischemia. , 2013, Journal of vascular surgery.
[8] G. Knapp,et al. Drug-eluting balloon angioplasty for in-stent restenosis: a systematic review and meta-analysis of randomised controlled trials , 2013, Heart.
[9] T. Albrecht,et al. Drug-coated balloons and their place in treating peripheral arterial disease , 2013, Expert review of medical devices.
[10] Adnan Kastrati,et al. Five‐year clinical outcomes of a polymer‐free sirolimus‐eluting stent versus a permanent polymer paclitaxel‐eluting stent: Final results of the intracoronary stenting and angiographic restenosis – test equivalence between two drug‐eluting stents (ISAR‐TEST) trial , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[11] D. Scheinert,et al. A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial. , 2012, Journal of the American College of Cardiology.
[12] T. Albrecht,et al. Paclitaxel-Coated Balloons Reduce Restenosis After Femoro-Popliteal Angioplasty: Evidence From the Randomized PACIFIER Trial , 2012, Circulation. Cardiovascular interventions.
[13] A. Cannavale,et al. Lower Limb Multilevel Treatment With Drug-Eluting Balloons: 6-Month Results From the DEBELLUM Randomized Trial , 2012, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.
[14] J. Granada,et al. Evaluation of efficacy and dose response of different paclitaxel-coated balloon formulations in a novel swine model of iliofemoral in-stent restenosis. , 2012, JACC. Cardiovascular interventions.
[15] F. Castriota,et al. Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry. , 2012, JACC. Cardiovascular interventions.
[16] D. Scheinert,et al. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. , 2012, Journal of vascular surgery.
[17] M. Joner,et al. Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[18] D. Scheinert,et al. First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. , 2011, Journal of the American College of Cardiology.
[19] G. Hubermont,et al. A Reliable Approach to Diabetic Neuroischemic Foot Wounds: Below-the-Knee Angiosome-Oriented Angioplasty , 2011, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.
[20] Dirk Mahnkopf,et al. Dose Response to Paclitaxel-Coated Balloon Catheters in the Porcine Coronary Overstretch and Stent Implantation Model , 2011, Investigative radiology.
[21] D. Scheinert,et al. PERIPHERAL VASCULAR DISEASE Original Studies Angiographic Patency and Clinical Outcome After Balloon-Angioplasty for Extensive Infrapopliteal Arterial Disease , 2010 .
[22] B. Cremers,et al. Paclitaxel-coated balloons - Survey of preclinical data. , 2010, Minerva cardioangiologica.
[23] G. Sangiorgi,et al. Optimization of drug‐eluting balloon use for safety and efficacy: Evaluation of the 2nd generation paclitaxel‐eluting DIOR‐balloon in porcine coronary arteries , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[24] S. Nanto,et al. Importance of the angiosome concept for endovascular therapy in patients with critical limb ischemia , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[25] E. Jude,et al. Peripheral arterial disease in diabetes—a review , 2010, Diabetic medicine : a journal of the British Diabetic Association.
[26] T. Zeller,et al. Recanalization of chronic occlusions of the superficial femoral artery using the outback™ re‐entry catheter: A single centre experience , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[27] K. Yamashita,et al. The stent-eluting drugs sirolimus and paclitaxel suppress healing of the endothelium by induction of autophagy. , 2009, The American journal of pathology.
[28] R. Pakala,et al. Drug-eluting balloon: the comeback kid? , 2009, Circulation. Cardiovascular interventions.
[29] S. Nanto,et al. Long-term results of endovascular therapy with nitinol stent implantation for TASC II A/B femoro-popliteal artery lesions: 4 years' experience. , 2009, Circulation journal : official journal of the Japanese Circulation Society.
[30] B. Hamm,et al. Inhibition of Restenosis in Femoropopliteal Arteries: Paclitaxel-Coated Versus Uncoated Balloon: Femoral Paclitaxel Randomized Pilot Trial , 2008, Circulation.
[31] M. Gyöngyösi,et al. Attainment of local drug delivery with paclitaxel-eluting balloon in porcine coronary arteries , 2008, Coronary artery disease.
[32] M. Romiti,et al. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. , 2008, Journal of vascular surgery.
[33] C. Claussen,et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. , 2008, The New England journal of medicine.
[34] K. Ouriel,et al. Angiography Underestimates Peripheral Atherosclerosis: Lumenography Revisited , 2008, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.
[35] L. Norgren,et al. Inter-society consensus for the management of peripheral arterial disease. , 2007, International angiology : a journal of the International Union of Angiology.
[36] D. Desilvey. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. , 2007, The American journal of geriatric cardiology.
[37] L. Norgren,et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, Journal of vascular surgery.
[38] Johannes Lammer,et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. , 2006, The New England journal of medicine.
[39] Christopher Piorkowski,et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. , 2005, Journal of the American College of Cardiology.
[40] M. Böhm,et al. Paclitaxel Balloon Coating, a Novel Method for Prevention and Therapy of Restenosis , 2004, Circulation.
[41] W. Fan. Possible mechanisms of paclitaxel-induced apoptosis. , 1999, Biochemical pharmacology.
[42] P. Heller. Paclitaxel and arterial smooth muscle cell proliferation. , 1998, Circulation.
[43] A. Küttner,et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. , 1997, Circulation.
[44] K. Johnston. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. , 1992, Radiology.
[45] Second European Consensus Document on chronic critical leg ischemia. , 1992, European journal of vascular surgery.